We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$726M
AUM Growth
+$18.2M
Cap. Flow
+$4.73M
Cap. Flow %
0.65%
Top 10 Hldgs %
40.72%
Holding
81
New
7
Increased
30
Reduced
28
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 44.52%
2 Technology 11.82%
3 Consumer Discretionary 11.3%
4 Industrials 11.25%
5 Miscellaneous 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNX icon
1
Cognex
CGNX
$10.5B
$38.4M 5.29%
739,400
+6,915
+0.9% +$409K
TIF
2
DELISTED
Tiffany & Co.
TIF
$33.4M 4.6%
342,336
-7,784
-2% -$803K
NEOG icon
3
Neogen
NEOG
$2.58B
$30.7M 4.23%
917,692
+15,975
+2% +$481K
ADI icon
4
Analog Devices
ADI
$176B
$30.2M 4.16%
331,695
+3,424
+1% +$312K
IDXX icon
5
Idexx Laboratories
IDXX
$42.2B
$29.3M 4.04%
153,230
-1,090
-0.7% -$201K
RTN
6
DELISTED
Raytheon Company
RTN
$28.8M 3.96%
133,322
+475
+0.4% +$98.3K
MA icon
7
Mastercard
MA
$507B
$27.3M 3.75%
155,615
-335
-0.2% -$57.3K
PODD icon
8
Insulet
PODD
$10.2B
$26.3M 3.62%
303,040
+755
+0.2% +$58.6K
BF.B icon
9
Brown-Forman Class B
BF.B
$12.3B
$26.1M 3.59%
479,536
-120,028
-20% -$5.69M
JNJ icon
10
Johnson & Johnson
JNJ
$663B
$25.2M 3.46%
196,291
-1,048
-0.5% -$142K
DHR icon
11
Danaher
DHR
$146B
$24.2M 3.33%
278,317
+4,924
+2% +$431K
ABMD
12
DELISTED
Abiomed Inc
ABMD
$23.3M 3.21%
80,180
-455
-0.6% -$115K
HON icon
13
Honeywell
HON
$66.4B
$22.9M 3.16%
175,644
+2,762
+2% +$382K
DXCM icon
14
DexCom
DXCM
$33.2B
$21.5M 2.96%
1,159,316
+37,136
+3% +$549K
INGN icon
15
Inogen
INGN
$144M
$20.6M 2.84%
167,915
+3,860
+2% +$471K
NVO
16
Novo Nordisk
NVO
$206B
$20M 2.75%
811,990
-970
-0.1% -$25.5K
BIIB icon
17
Biogen
BIIB
$32.6B
$19.8M 2.72%
72,227
-1,390
-2% -$431K
SBUX icon
18
Starbucks
SBUX
$119B
$19.2M 2.64%
331,373
+15,903
+5% +$919K
ROST icon
19
Ross Stores
ROST
$73.7B
$17.2M 2.37%
220,983
+7,503
+4% +$595K
NVRO
20
DELISTED
NEVRO CORP.
NVRO
$14.6M 2.01%
168,805
+9,260
+6% +$748K
HSIC icon
21
Henry Schein
HSIC
$10B
$13.2M 1.82%
251,255
-1,773
-0.7% -$98.2K
AMGN icon
22
Amgen
AMGN
$236B
$13.1M 1.81%
77,024
-750
-1% -$138K
MTD icon
23
Mettler-Toledo International
MTD
$27B
$12.7M 1.75%
22,110
+1,325
+6% +$833K
XRAY icon
24
Dentsply Sirona
XRAY
$2.27B
$12.6M 1.74%
250,918
+5,036
+2% +$297K
ABBV icon
25
AbbVie
ABBV
$453B
$11.8M 1.62%
124,550
-1,300
-1% -$143K

Similar funds

Tirschwell & Loewy's Q1 2018 Portfolio in Review

As of Q1 2018, Tirschwell & Loewy held 81 positions worth $726M, up 2.6% from $708M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Tirschwell & Loewy's Q1 2018 filing shows 7 new, 30 increased, 28 reduced and 3 closed positions. Its largest new stake was Automatic Data Processing: 3,500 shares worth $397K. The largest sale was Brown-Forman Class B, an estimated $5.69M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Tirschwell & Loewy's largest Q1 2018 buy was Automatic Data Processing: 3,500 shares worth $397K.
  • Tirschwell & Loewy added most to United Parcel Service in Q1 2018, an estimated $1.89M increase.
  • Tirschwell & Loewy's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $5.69M.
  • Tirschwell & Loewy fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.87M.
  • Tirschwell & Loewy's ten largest holdings make up 41% of its $726M portfolio in Q1 2018.
  • Tirschwell & Loewy opened 7 new positions and closed 3 in Q1 2018.
  • Tirschwell & Loewy's portfolio value rose 2.6% quarter-over-quarter to $726M.

Based on Tirschwell & Loewy's 13F filing for Q1 2018, filed 16 Apr 2018.